Forest has well-established franchises in the therapeutic areas of the central nervous and cardiovascular systems, and we are always exploring new product opportunities that address a range of health conditions. Our principal brands include Bystolic® (nebivolol), Daliresp™ (roflumilast), Lexapro® (escitalopram oxalate), Namenda® (memantine HCl), Savella®(milnacipran HCl), Teflaro™ (ceftaroline fosamil) for injection, and Viibryd™ (vilazodone HCl). Forest identifies, develops, and delivers pharmaceutical products that make a difference in people's lives.
Looking for a particular Forest Research employee's phone or email?
The Forest Research annual revenue was $14.8 million in 2026.
Anjana Bose is the Executive Director of Forest Research.
92 people are employed at Forest Research.
Forest Research is based in Jersey City, New Jersey.
The NAICS codes for Forest Research are [3254, 54, 32, 541, 32541, 325].
The SIC codes for Forest Research are [28, 283].